The UK ophthalmic drugs market is being shaped by several powerful demographic, technological, and healthcare policy drivers that collectively determine its growth trajectory. Understanding these forces is essential for stakeholders seeking to navigate this dynamic and increasingly competitive space. One of the primary growth drivers is the demographic shift toward an older population. The UK,...